These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20039803)

  • 1. Piglet models of acute or chronic Clostridium difficile illness.
    Steele J; Feng H; Parry N; Tzipori S
    J Infect Dis; 2010 Feb; 201(3):428-34. PubMed ID: 20039803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain.
    Pawlowski SW; Calabrese G; Kolling GL; Platts-Mills J; Freire R; AlcantaraWarren C; Liu B; Sartor RB; Guerrant RL
    J Infect Dis; 2010 Dec; 202(11):1708-12. PubMed ID: 20977342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of oral tigecycline treatment on Clostridium difficile infection in gnotobiotic piglets.
    Kim HB; Zhang Q; Sun X; Beamer G; Wang Y; Tzipori S
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7560-4. PubMed ID: 25267665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains.
    Theriot CM; Koumpouras CC; Carlson PE; Bergin II; Aronoff DM; Young VB
    Gut Microbes; 2011; 2(6):326-34. PubMed ID: 22198617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the extent of Clostridium difficile colonisation and toxin accumulation in sows and neonatal piglets.
    Grześkowiak Ł; Zentek J; Vahjen W
    Anaerobe; 2016 Aug; 40():5-9. PubMed ID: 27108595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of probiotic kefir to mice with Clostridium difficile infection exacerbates disease.
    Spinler JK; Brown A; Ross CL; Boonma P; Conner ME; Savidge TC
    Anaerobe; 2016 Aug; 40():54-7. PubMed ID: 27180007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MBX-500 is effective for treatment of Clostridium difficile infection in gnotobiotic piglets.
    Steele J; Zhang Q; Beamer G; Butler M; Bowlin T; Tzipori S
    Antimicrob Agents Chemother; 2013 Aug; 57(8):4039-41. PubMed ID: 23689716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile in piglets in the Czech Republic.
    Goldová J; Malinová A; Indra A; Vítek L; Branny P; Jirásková A
    Folia Microbiol (Praha); 2012 Mar; 57(2):159-61. PubMed ID: 22354381
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving the reproducibility of the NAP1/B1/027 epidemic strain R20291 in the hamster model of infection.
    Kelly ML; Ng YK; Cartman ST; Collery MM; Cockayne A; Minton NP
    Anaerobe; 2016 Jun; 39():51-3. PubMed ID: 26946361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 11. Clostridium difficile infection: new developments in epidemiology and pathogenesis.
    Rupnik M; Wilcox MH; Gerding DN
    Nat Rev Microbiol; 2009 Jul; 7(7):526-36. PubMed ID: 19528959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile: clinical disease and diagnosis.
    Knoop FC; Owens M; Crocker IC
    Clin Microbiol Rev; 1993 Jul; 6(3):251-65. PubMed ID: 8358706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant, non-antibiotic associated Clostridium difficile colitis following Salmonella gastroenteritis.
    Halvorson SA; Cedfeldt AS; Hunter AJ
    J Gen Intern Med; 2011 Jan; 26(1):95-7. PubMed ID: 20697966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis.
    Vardakas KZ; Konstantelias AA; Loizidis G; Rafailidis PI; Falagas ME
    Int J Infect Dis; 2012 Nov; 16(11):e768-73. PubMed ID: 22921930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of two-stage algorithm in the diagnosis of patients with low levels of Clostridium difficile toxins A/B in feces confirmed by using enzyme immunoassay].
    Nurzyńska G; Pituch H; Kamola R; Kopeć ES
    Med Dosw Mikrobiol; 2013; 65(4):263-8. PubMed ID: 24730214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.
    Sambol SP; Merrigan MM; Lyerly D; Gerding DN; Johnson S
    Infect Immun; 2000 Oct; 68(10):5480-7. PubMed ID: 10992443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible role for Clostridium difficile in the etiology of calf enteritis.
    Hammitt MC; Bueschel DM; Keel MK; Glock RD; Cuneo P; DeYoung DW; Reggiardo C; Trinh HT; Songer JG
    Vet Microbiol; 2008 Mar; 127(3-4):343-52. PubMed ID: 17964088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional profiling of Clostridium difficile and Caco-2 cells during infection.
    Janvilisri T; Scaria J; Chang YF
    J Infect Dis; 2010 Jul; 202(2):282-90. PubMed ID: 20521945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection.
    Frisbee AL; Saleh MM; Young MK; Leslie JL; Simpson ME; Abhyankar MM; Cowardin CA; Ma JZ; Pramoonjago P; Turner SD; Liou AP; Buonomo EL; Petri WA
    Nat Commun; 2019 Jun; 10(1):2712. PubMed ID: 31221971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemically administered IgG anti-toxin antibodies protect the colonic mucosa during infection with Clostridium difficile in the piglet model.
    Cohen OR; Steele JA; Zhang Q; Schmidt DJ; Wang Y; Hamel PE; Beamer G; Xu B; Tzipori S
    PLoS One; 2014; 9(10):e111075. PubMed ID: 25347821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.